Status:
COMPLETED
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
Lead Sponsor:
Emory University
Collaborating Sponsors:
Georgia Tech Foundation
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device...
Detailed Description
A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in association with cases of severe respiratory illness and pneumonia (COVID-19) in Wuhan City, Hubei Pr...
Eligibility Criteria
Inclusion
- Being treated for an acute respiratory illness either as inpatients or outpatients at Emory University Hospital
- English is a primary spoken language
Exclusion
- none
- Inclusion Criteria for Healthy Volunteers:
- Prior registration in an adult participant database and agreed to be contacted for future studies
- English is a primary spoken language
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2022
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04912895
Start Date
April 14 2021
End Date
August 5 2022
Last Update
September 7 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
2
Emory Children's Center
Atlanta, Georgia, United States, 30322
3
Emory University Hospital
Atlanta, Georgia, United States, 30322
4
Wesley Woods Center
Atlanta, Georgia, United States, 30329